163 related articles for article (PubMed ID: 24526905)
1. Long term survival analysis of hepatectomy for neuroendocrine tumour liver metastases.
Cheung TT; Chok KS; Chan AC; Tsang S; Dai JW; Lang BH; Yau T; Chan SC; Poon RT; Fan ST; Lo CM
ScientificWorldJournal; 2014; 2014():524045. PubMed ID: 24526905
[TBL] [Abstract][Full Text] [Related]
2. Liver Resection for Neuroendocrine Tumor Liver Metastases Within Milan Criteria for Liver Transplantation.
Ruzzenente A; Bagante F; Bertuzzo F; Aldrighetti L; Campagnaro T; Ercolani G; Conci S; Giuliante F; Dore A; Ferrero A; Torzilli G; Grazi GL; Ratti F; Cucchetti A; De Rose AM; Russolillo N; Cimino M; Perri P; Guglielmi A; Iacono C
J Gastrointest Surg; 2019 Jan; 23(1):93-100. PubMed ID: 30242647
[TBL] [Abstract][Full Text] [Related]
3. Surgical strategy for liver metastases of neuroendocrine tumors.
Tsuchikawa T; Hirano S; Tanaka E; Kato K; Matsumoto J; Nakayama T; Tabata Y; Shichinohe T
Hepatogastroenterology; 2012 May; 59(115):921-3. PubMed ID: 22024223
[TBL] [Abstract][Full Text] [Related]
4. Synchronous resection of primary and liver metastases for neuroendocrine tumors.
Gaujoux S; Gonen M; Tang L; Klimstra D; Brennan MF; D'Angelica M; Dematteo R; Allen PJ; Jarnagin W; Fong Y
Ann Surg Oncol; 2012 Dec; 19(13):4270-7. PubMed ID: 22752376
[TBL] [Abstract][Full Text] [Related]
5. Early recurrence of well-differentiated (G1) neuroendocrine liver metastasis after curative-intent surgery: Risk factors and outcome.
Xiang JX; Zhang XF; Weiss M; Aldrighetti L; Poultsides GA; Bauer TW; Fields RC; Maithel SK; Marques HP; Pawlik TM
J Surg Oncol; 2018 Dec; 118(7):1096-1104. PubMed ID: 30261105
[TBL] [Abstract][Full Text] [Related]
6. Neuroendocrine liver metastasis: The chance to be cured after liver surgery.
Bagante F; Spolverato G; Merath K; Postlewait LM; Poultsides GA; Mullen MG; Bauer TW; Fields RC; Lamelas J; Marques HP; Aldrighetti L; Tran T; Maithel SK; Pawlik TM
J Surg Oncol; 2017 May; 115(6):687-695. PubMed ID: 28146608
[TBL] [Abstract][Full Text] [Related]
7. Perioperative and long-term outcomes of laparoscopic liver resections for non-colorectal liver metastases.
Triantafyllidis I; Gayet B; Tsiakyroudi S; Tabchouri N; Beaussier M; Bennamoun M; Sarran A; Lefevre M; Louvet C; Fuks D
Surg Endosc; 2020 Sep; 34(9):3833-3844. PubMed ID: 31586246
[TBL] [Abstract][Full Text] [Related]
8. Management of Neuroendocrine Tumor Liver Metastases: Long-Term Outcomes and Prognostic Factors from a Large Prospective Database.
Fairweather M; Swanson R; Wang J; Brais LK; Dutton T; Kulke MH; Clancy TE
Ann Surg Oncol; 2017 Aug; 24(8):2319-2325. PubMed ID: 28303430
[TBL] [Abstract][Full Text] [Related]
9. Total hepatectomy and liver transplantation for metastatic neuroendocrine tumors of the pancreas - a single center experience with ten patients.
Lang H; Schlitt HJ; Schmidt H; Flemming P; Nashan B; Scheumann GF; Oldhafer KJ; Manns MP; Raab R
Langenbecks Arch Surg; 1999 Aug; 384(4):370-7. PubMed ID: 10473858
[TBL] [Abstract][Full Text] [Related]
10. Hepatic Resection for Non-functional Neuroendocrine Liver Metastasis: Does the Presence of Unresected Primary Tumor or Extrahepatic Metastatic Disease Matter?
Xiang JX; Zhang XF; Beal EW; Weiss M; Aldrighetti L; Poultsides GA; Bauer TW; Fields RC; Maithel SK; Marques HP; Pawlik TM
Ann Surg Oncol; 2018 Dec; 25(13):3928-3935. PubMed ID: 30218247
[TBL] [Abstract][Full Text] [Related]
11. Adjunctive radiofrequency ablation of metastatic neuroendocrine cancer to the liver complements surgical resection.
Taner T; Atwell TD; Zhang L; Oberg TN; Harmsen WS; Slettedahl SW; Kendrick ML; Nagorney DM; Que FG
HPB (Oxford); 2013 Mar; 15(3):190-5. PubMed ID: 23374359
[TBL] [Abstract][Full Text] [Related]
12. Surgical resection improves the outcome of the patients with neuroendocrine tumor liver metastases: large data from Asia.
Du S; Wang Z; Sang X; Lu X; Zheng Y; Xu H; Xu Y; Chi T; Zhao H; Wang W; Cui Q; Zhong S; Huang J; Mao Y
Medicine (Baltimore); 2015 Jan; 94(2):e388. PubMed ID: 25590842
[TBL] [Abstract][Full Text] [Related]
13. Outcomes of laparoscopic tumor ablation for neuroendocrine liver metastases: a 20-year experience.
Kose E; Kahramangil B; Aydin H; Donmez M; Takahashi H; Aucejo F; Siperstein A; Berber E
Surg Endosc; 2020 Jan; 34(1):249-256. PubMed ID: 30945061
[TBL] [Abstract][Full Text] [Related]
14. Resection of liver metastasis from neuroendocrine tumors: evaluation of results and prognostic factors.
Valadares LJ; Costa Junior W; Ribeiro HS; Diniz AL; Coimbra FJ; Herman P
Rev Col Bras Cir; 2015; 42(1):25-31. PubMed ID: 25992697
[TBL] [Abstract][Full Text] [Related]
15. Timing of disease occurrence and hepatic resection on long-term outcome of patients with neuroendocrine liver metastasis.
Zhang XF; Beal EW; Weiss M; Aldrighetti L; Poultsides GA; Bauer TW; Fields RC; Maithel SK; Marques HP; Pawlik TM
J Surg Oncol; 2018 Feb; 117(2):171-181. PubMed ID: 28940257
[TBL] [Abstract][Full Text] [Related]
16. Conditional disease-free survival after curative-intent liver resection for neuroendocrine liver metastasis.
Sahara K; Merath K; Tsilimigras DI; Hyer JM; Guglielmi A; Aldrighetti L; Weiss M; Fields RC; Poultsides GA; Maithel SK; Endo I; Pawlik TM; Other Members Of The U S Neuroendocrine Tumor Study Group
J Surg Oncol; 2019 Dec; 120(7):1087-1095. PubMed ID: 31550406
[TBL] [Abstract][Full Text] [Related]
17. Analysis of long-term survival after hepatectomy for isolated liver metastasis of gastrointestinal stromal tumour.
Cheung TT; Chok KS; Chan AC; Yau TC; Chan SC; Poon RT; Fan ST; Lo CM
ANZ J Surg; 2014 Nov; 84(11):827-31. PubMed ID: 23782558
[TBL] [Abstract][Full Text] [Related]
18. Long-term survival after surgical management of neuroendocrine hepatic metastases.
Glazer ES; Tseng JF; Al-Refaie W; Solorzano CC; Liu P; Willborn KA; Abdalla EK; Vauthey JN; Curley SA
HPB (Oxford); 2010 Aug; 12(6):427-33. PubMed ID: 20662794
[TBL] [Abstract][Full Text] [Related]
19. Alternative lengthening of telomeres predicts site of origin in neuroendocrine tumor liver metastases.
Dogeas E; Karagkounis G; Heaphy CM; Hirose K; Pawlik TM; Wolfgang CL; Meeker A; Hruban RH; Cameron JL; Choti MA
J Am Coll Surg; 2014 Apr; 218(4):628-35. PubMed ID: 24655849
[TBL] [Abstract][Full Text] [Related]
20. Liver-directed therapy for neuroendocrine neoplasm hepatic metastasis prolongs survival following progression after initial surgery.
Saxena A; Chua TC; Zhao J; Morris DL
J Surg Oncol; 2012 Mar; 105(4):342-50. PubMed ID: 22006355
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
